We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+34.33%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$4.17B
AUM Growth
+$193M
(+4.9%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
41.32%
Holding
120
New
16
Increased
14
Reduced
24
Closed
15
Top Buys
| 1 |
Danaher
DHR
|
+$52.4M |
| 2 |
Cigna
CI
|
+$48.2M |
| 3 |
United Therapeutics
UTHR
|
+$38.6M |
| 4 |
Ascendis Pharma A/S
ASND
|
+$29.4M |
| 5 |
Oric Pharmaceuticals
ORIC
|
+$28.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$93.6M |
| 3 |
Tenet Healthcare
THC
|
+$81.8M |
| 4 |
Boston Scientific
BSX
|
+$39.8M |
| 5 |
Cytokinetics
CYTK
|
+$35.6M |
Sector Composition
| 1 | Healthcare | 99.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioCryst Pharmaceuticals
BCRX
$2.39B
| $6.84M | 0.16% |
+901,500
| New | +$7.51M |
|
77
Milestone Pharmaceuticals
MIST
$158M
| $6.44M | 0.15% |
+3,221,828
| New | +$5.67M |
|
|
RPTX
78
DELISTED
Repare Therapeutics
RPTX
| $5.85M | 0.14% |
3,322,488
| – | – |
|
79
InspireMD
NSPR
$33.7M
| $5.14M | 0.12% |
2,133,405
| – | – |
|
|
BIOA
80
BioAge Labs
BIOA
$1.01B
| $4.65M | 0.11% |
790,901
-131,058
| -14% | -$614K |
|
|
JBIO
81
Jade Biosciences
JBIO
$1.33B
| $4.58M | 0.11% |
531,163
| – | – |
|
82
Q32 Bio
QTTB
$266M
| $4.46M | 0.11% |
2,252,987
| – | – |
|
|
DFTX
83
Definium Therapeutics
DFTX
$6.06B
| $4.34M | 0.1% |
+367,824
| New | +$3.43M |
|
84
Celcuity
CELC
$4.46B
| $4.15M | 0.1% |
+84,020
| New | +$3.36M |
|
85
Immatics
IMTX
$1.29B
| $3.98M | 0.1% |
466,601
-253,300
| -35% | -$1.56M |
|
|
IMA
86
ImageneBio Inc
IMA
$67.8M
| $3.09M | 0.07% |
378,556
+83,609
| +28% | +$1.11M |
|
87
Insmed
INSM
$23.8B
| $1.94M | 0.05% |
13,459
| – | – |
|
88
AtaiBeckley Inc
ATAI
$1.97B
| $1.84M | 0.04% |
+347,000
| New | +$1.41M |
|
89
Korro Bio
KRRO
$188M
| $1.55M | 0.04% |
32,400
| – | – |
|
|
MURA
90
DELISTED
Mural Oncology
MURA
| $1.22M | 0.03% |
588,800
| – | – |
|
91
Traws Pharma
TRAW
$9.97M
| $1.12M | 0.03% |
605,531
| – | – |
|
92
Alto Neuroscience
ANRO
$976M
| $1M | 0.02% |
250,000
| – | – |
|
93
Lyell Immunopharma
LYEL
$349M
| $840K | 0.02% |
51,727
| – | – |
|
|
KZR
94
DELISTED
Kezar Life Sciences
KZR
| $752K | 0.02% |
192,700
| – | – |
|
95
Xeris Biopharma Holdings
XERS
$1.5B
| $655K | 0.02% |
80,420
| – | – |
|
96
Passage Bio
PASG
$15.8M
| $474K | 0.01% |
59,046
-243,719
| -80% | -$1.7M |
|
|
DHAI
97
DELISTED
DIH Holdings US
DHAI
| $358K | 0.01% |
76,600
| – | – |
|
98
AbCellera Biologics
ABCL
$2.06B
| – | – |
-3,344,568
| Closed | -$11.5M |
|
99
Abbott
ABT
$155B
| – | – |
0
| – | – |
|
100
Agios Pharmaceuticals
AGIO
$2.37B
| – | – |
-557,900
| Closed | -$18.6M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM